Toward the end of the year 2019, there was the eruption of an acute respiratory syndrome, which is widely referred as coronavirus disease (COVID-19) from Wuhan, Hubei Province. The disease causes a range of respiratory illnesses, which are fatal. The COVID-19 disease has spread globally and has significantly impacted the health delivery systems, travel regulations, and economic activities and has posed and upsurge of responsibilities for the frontline healthcare workers. Due to the nature of the COVID-19 disease, it has typically caused complications which include pneumonia, multiple organ dysfunction together with renal failure, and acute respiratory distress syndrome. As of date, there is no approved vaccine or treatment for COVID-19 though there are ongoing research studies to formulate a treatment. COVID-19 is highly contagious, and the risk of infection is higher for patients with immunesuppressed patients than regular patients. The immunesuppressed conditions include cancer, HIV, and patients with solid organ transplants (SOT). This paper aims to review the risk and impact of COVID-19 on immunesuppressed patients, with a focus on cancer, HIV, and patients with SOT and the essence of special parameters for their care and management. Despite the fatal effects of this global pandemic, the findings of this study indicate the high risk which immunosuppressed patients have to contract the disease; thus, the governments and health delivery systems have to offer them extra support and treatment.

中文翻译：

---

COVID-19大流行对免疫抑制患者的风险和影响：癌症，HIV和实体器官移植接受者。

到2019年底，湖北省武汉市爆发了一种急性呼吸道综合症，被广泛称为冠状病毒病（COVID-19）。该疾病会导致一系列致命的呼吸道疾病。COVID-19疾病已在全球蔓延，对健康提供系统，旅行法规和经济活动产生了重大影响，并构成了对一线医护人员的责任，并且这种责任日益增加。由于COVID-19疾病的性质，通常会引起并发症，包括肺炎，多器官功能不全以及肾功能衰竭和急性呼吸窘迫综合征。迄今为止，尽管有正在进行的研究来制定治疗方案，但尚无批准的COVID-19疫苗或治疗方案。COVID-19具有高度传染性，免疫抑制患者的感染风险比普通患者高。免疫抑制的疾病包括癌症，HIV和患有实体器官移植（SOT）的患者。本文旨在回顾COVID-19对免疫抑制患者的风险和影响，重点关注癌症，HIV和SOT患者以及特殊护理和管理参数的本质。尽管这种全球性大流行具有致命的影响，但这项研究的结果表明，免疫抑制的患者感染该疾病的风险很高。因此，政府和卫生保健系统必须向他们提供额外的支持和治疗。和实体器官移植（SOT）患者。本文旨在回顾COVID-19对免疫抑制患者的风险和影响，重点关注癌症，HIV和SOT患者以及特殊护理和管理参数的本质。尽管这种全球性大流行具有致命的影响，但这项研究的结果表明，免疫抑制的患者感染该疾病的风险很高。因此，政府和卫生保健系统必须向他们提供额外的支持和治疗。和实体器官移植（SOT）患者。本文旨在回顾COVID-19对免疫抑制患者的风险和影响，重点关注癌症，HIV和SOT患者以及特殊护理和管理参数的本质。尽管这种全球性大流行具有致命的影响，但这项研究的结果表明，免疫抑制的患者感染该疾病的风险很高。因此，政府和卫生保健系统必须向他们提供额外的支持和治疗。这项研究的结果表明，免疫抑制患者患该病的风险很高。因此，政府和卫生保健系统必须向他们提供额外的支持和治疗。这项研究的结果表明，免疫抑制患者患该病的风险很高。因此，政府和卫生保健系统必须向他们提供额外的支持和治疗。